• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OPTICROSS? HD; TRANSDUCER, ULTRASONIC, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OPTICROSS? HD; TRANSDUCER, ULTRASONIC, DIAGNOSTIC Back to Search Results
Model Number H74939352050
Medical Device Problem Codes Entrapment of Device (1212); Nonstandard Device (1420)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/03/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve the device status, but it was unable to be obtained.
 
Event or Problem Description
It was reported that catheter issue occurred.The 80% stenosed target lesion was located in the moderately tortuous and moderately calcified coronary artery.An opticross hd imaging catheter was selected for ultrasound examination of the target lesion.During the procedure, the guidewire became trapped in the catheter and both were removed together.The guidewire was able to be separated from the catheter outside the patient.The procedure was completed using another method without any patient complications.
 
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve the device status, but it was unable to be obtained.The device was returned for analysis.Visual and microscopic inspection revealed the sheath was kinked and the guidewire exit port was damage.A test guidewire was inserted, and there was no indication of resistance when tracking the guidewire into the catheter.
 
Event or Problem Description
It was reported that catheter issue occurred.The 80% stenosed target lesion was located in the moderately tortuous and moderately calcified coronary artery.An opticross hd imaging catheter was selected for ultrasound examination of the target lesion.During the procedure, the guidewire became trapped in the catheter and both were removed together.The guidewire was able to be separated from the catheter outside the patient.The procedure was completed using another method without any patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTICROSS? HD
Common Device Name
TRANSDUCER, ULTRASONIC, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key23766441
Report Number2124215-2025-90066
Device Sequence Number9743192
Product Code OBJ
UDI-Device Identifier00191506035419
UDI-Public(01)00191506035419(17)260829(10)37334256
Combination Product (Y/N)N
Initial Reporter CountrySN
PMA/510(K) Number
K213593
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/29/2026
Device Model NumberH74939352050
Device Catalogue NumberH74939352050
Device Lot Number0037334256
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/05/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/16/2025
Supplement Date Received by Manufacturer12/18/2025
Initial Report FDA Received Date12/10/2025
Supplement Report FDA Received Date01/07/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/29/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ASAHI GUIDEWIRE; ASAHI GUIDEWIRE
Patient SexUnknown
-
-